Risk of intraocular pressure elevation after topical steroids in children and adults: A systematic review

Steroid-induced ocular hypertension in the pediatric age group

(2018) Abeer T Al Hanaineh et al.   EUROPEAN JOURNAL OF OPHTHALMOLOGY

Fluorometholone 0.1% as Ancillary Therapy for Trachomatous Trichiasis Surgery: Randomized Clinical Trial

(2018) John H. Kempen et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Submicron loteprednol etabonate ophthalmic gel 0.38% for the treatment of inflammation and pain after cataract surgery

(2018) Raymond Fong et al.   JOURNAL OF CATARACT AND REFRACTIVE SURGERY

Steroid-induced glaucoma in the pediatric population

(2017) Brenda Nuyen et al.   JOURNAL OF AAPOS

Difluprednate 0.05% versus Prednisolone Acetate 1% for Endogenous Anterior Uveitis: Pooled Efficacy Analysis of Two Phase 3 Studies

(2017) John D. Sheppard et al.   OCULAR IMMUNOLOGY AND INFLAMMATION

Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine

(2017) M. Elizabeth Fini et al.   PROGRESS IN RETINAL AND EYE RESEARCH

Outcome of Ocular Steroid Hypertensive Response in Children

(2016) Savleen Kaur et al.   JOURNAL OF GLAUCOMA

Loteprednol Etabonate 0.5%/Tobramycin 0.3% Compared with Dexamethasone 0.1%/Tobramycin 0.3% for the Treatment of Blepharitis

(2016) Timothy L. Comstock et al.   OCULAR IMMUNOLOGY AND INFLAMMATION

Loteprednol Etabonate 0.5% Gel Vs. Prednisolone Acetate 1% Solution After Descemet Membrane Endothelial Keratoplasty

(2015) Marianne O. Price et al.   CORNEA

Prospective Randomized Trial Comparing Efficacy of Topical Loteprednol Etabonate 0.5% Versus Cyclosporine-A 0.05% for Treatment of Dry Eye Syndrome Following Hematopoietic Stem Cell Transplantation

(2015) Grace E. Boynton et al.   CORNEA

Effects of Topical Loteprednol Etabonate on Tear Cytokines and Clinical Outcomes in Moderate and Severe Meibomian Gland Dysfunction: Randomized Clinical Trial

(2014) Hun Lee et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Loteprednol Etabonate Ophthalmic Gel 0.5% Following Cataract Surgery: Integrated Analysis of Two Clinical Studies

(2013) Rajesh K. Rajpal et al.   ADVANCES IN THERAPY

Loteprednol Etabonate Suspension 0.2% Administered QID Compared With Olopatadine Solution 0.1% Administered BID in the Treatment of Seasonal Allergic Conjunctivitis: A Multicenter, Randomized, Investigator-Masked, Parallel Group Study in Chinese Patients

(2012) Lan Gong et al.   CLINICAL THERAPEUTICS

A multicenter, randomized, parallel-group, clinical trial comparing the safety and efficacy of loteprednol etabonate 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of Chinese patients with blepharokeratoconjunctivitis

(2012) Minjie Chen et al.   CURRENT MEDICAL RESEARCH AND OPINION

Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery

(2012) Stephen S. Lane et al.   JOURNAL OF CATARACT AND REFRACTIVE SURGERY

Safety and Tolerability of Loteprednol Etabonate 0.5% and Tobramycin 0.3% Ophthalmic Suspension in Pediatric Subjects

(2012) Timothy L. Comstock et al.   PEDIATRIC DRUGS

A Multicenter Randomized Controlled Fellow Eye Trial of Pulse-Dosed Difluprednate 0.05% Versus Prednisolone Acetate 1% in Cataract Surgery

(2011) Eric D. Donnenfeld et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Single perioperative subconjunctival steroid depot versus postoperative steroid eyedrops to prevent intraocular inflammation and macular edema after cataract surgery

(2011) Myrthe Dieleman et al.   JOURNAL OF CATARACT AND REFRACTIVE SURGERY

Evaluation of clinical efficacy and safety of tobramycin/dexamethasone ophthalmic suspension 0.3%/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis/blepharoconjunctivitis

(2010) Gail L. Torkildsen et al.   CURRENT MEDICAL RESEARCH AND OPINION

Durezol® (Difluprednate Ophthalmic Emulsion 0.05%) Compared with Pred Forte® 1% Ophthalmic Suspension in the Treatment of Endogenous Anterior Uveitis

(2010) C. Stephen Foster et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Penetration of topical and subconjunctival corticosteroids into human aqueous humour and its therapeutic significance

(2009) M A Awan et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Effects of Loteprednol/Tobramycin Versus Dexamethasone/Tobramycin on Intraocular Pressure in Healthy Volunteers

(2009) Edward J Holland et al.   CORNEA

Visual Loss Caused by Corticosteroid-Induced Glaucoma: How to Avoid It

(2009) George L. Spaeth et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES